From SARS to MERS: evidence and speculation

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel zoonotic pathogen. In 2012, the infectious outbreak caused by MERS-CoV in Saudi Arabia has spread to more than 1600 patients in 26 countries, resulting in over 600 deaths.Without a travel history, few clinical and radiological features can reliably differentiate MERS from SARS. But in real world, comparing with SARS, MERS presents more vaguely defined epidemiology, more severe symptoms, and higher case fatality rate. In this review, we summarize the recent findings in the field of MERS-CoV, especially its molecular virology, interspecies mechanisms, clinical features, antiviral therapies, and the further investigation into this disease. As a newly emerging virus, many questions are not fully answered, including the exact mode of transmission chain, geographical distribution, and animal origins. Furthermore, a new protocol needs to be launched to rapidly evaluate the effects of unproven antiviral drugs and vaccine to fasten the clinical application of new drugs.

[1]  Amit Kapoor,et al.  Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia , 2013, Emerging infectious diseases.

[2]  K. Yuen,et al.  Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein , 2014, Science Translational Medicine.

[3]  M. Titécat,et al.  Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside? , 2014, PloS one.

[4]  Noha H Farag,et al.  Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Lu Lu,et al.  Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor , 2014, Nature Communications.

[6]  M. Koopmans,et al.  High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014 , 2015, Infection ecology & epidemiology.

[7]  P. Woo,et al.  Genetic Characterization of Betacoronavirus Lineage C Viruses in Bats Reveals Marked Sequence Divergence in the Spike Protein of Pipistrellus Bat Coronavirus HKU5 in Japanese Pipistrelle: Implications for the Origin of the Novel Middle East Respiratory Syndrome Coronavirus , 2013, Journal of Virology.

[8]  D. Dimitrov,et al.  Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections , 2014, Microbes and Infection.

[9]  D. Cummings,et al.  Hospital outbreak of Middle East respiratory syndrome coronavirus. , 2013, The New England journal of medicine.

[10]  L. Poon,et al.  Absence of MERS-Coronavirus in Bactrian Camels, Southern Mongolia, November 2014 , 2015, Emerging infectious diseases.

[11]  B. Murphy,et al.  An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus , 2004, Nature Medicine.

[12]  R. Baric,et al.  Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus , 2014, Proceedings of the National Academy of Sciences.

[13]  Sulaiman Almohaimeed,et al.  Middle East respiratory syndrome coronavirus in children , 2015, Saudi medical journal.

[14]  Z. Memish,et al.  Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia , 2014, International Journal of Infectious Diseases.

[15]  H. Feldmann,et al.  Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin , 2013, Scientific Reports.

[16]  T. Kuiken,et al.  Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets , 2004, The Lancet.

[17]  M. Denison,et al.  Severe Acute Respiratory Syndrome Coronavirus Pathogenesis, Disease and Vaccines: An Update , 2004, The Pediatric infectious disease journal.

[18]  Christian Drosten,et al.  Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.

[19]  Igor E. Agranovski,et al.  Survival of aerosolized coronavirus in the ambient air , 2017, Journal of Aerosol Science.

[20]  D. Dimitrov,et al.  Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies , 2014, Journal of Virology.

[21]  Z. Memish,et al.  Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study , 2014, Clinical Microbiology and Infection.

[22]  Su-Jin Park,et al.  Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  William B. Karesh,et al.  Middle East Respiratory Syndrome Coronavirus Quasispecies That Include Homologues of Human Isolates Revealed through Whole-Genome Analysis and Virus Cultured from Dromedary Camels in Saudi Arabia , 2014, mBio.

[24]  Z. Memish,et al.  Severe acute respiratory syndrome vs. the Middle East respiratory syndrome , 2014, Current opinion in pulmonary medicine.

[25]  A. Arifi,et al.  Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection , 2014, Annals of Internal Medicine.

[26]  Chantal Reusken,et al.  Human Betacoronavirus 2c EMC/2012–related Viruses in Bats, Ghana and Europe , 2013, Emerging infectious diseases.

[27]  T. Bestebroer,et al.  MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment , 2013, The Journal of general virology.

[28]  M. Müller,et al.  In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection , 2013, Virology Journal.

[29]  Jincun Zhao,et al.  Receptor Variation and Susceptibility to Middle East Respiratory Syndrome Coronavirus Infection , 2014, Journal of Virology.

[30]  K. To,et al.  Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus , 2013, Journal of Infection.

[31]  K. Yuen,et al.  Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response , 2014, Journal of Virology.

[32]  Shibo Jiang,et al.  A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein , 2014, Journal of Virology.

[33]  Lisa E. Gralinski,et al.  Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus , 2013, mBio.

[34]  A. Osterhaus,et al.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.

[35]  R. Baric,et al.  Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution , 2014, Proceedings of the National Academy of Sciences.

[36]  C. N. Brorn,et al.  WHO? , 1896 .

[37]  N. Lurie,et al.  Combating Emerging Threats--Accelerating the Availability of Medical Therapies. , 2015, The New England journal of medicine.

[38]  Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia , 2018, Saudi Medical Journal.

[39]  Christian Drosten,et al.  Evidence for camel-to-human transmission of MERS coronavirus. , 2014, The New England journal of medicine.

[40]  Y. Guan,et al.  The severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[41]  J. Segalés,et al.  An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels , 2016, Science.

[42]  Wenhui Li,et al.  Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Jihad Ghandour,et al.  Middle East Respiratory Syndrome Coronavirus: A Case-Control Study of Hospitalized Patients , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  J. McLellan,et al.  Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4 , 2014, Journal of Virology.

[45]  Malik Peiris,et al.  Middle East respiratory syndrome , 2015, The Lancet.

[46]  Z. Memish,et al.  Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study , 2014, The Lancet Infectious Diseases.

[47]  S. Perlman,et al.  Coronaviruses: An Overview of Their Replication and Pathogenesis , 2015, Methods in molecular biology.

[48]  T. Kuiken,et al.  Asymptomatic Middle East Respiratory Syndrome Coronavirus Infection in Rabbits , 2015, Journal of Virology.

[49]  Z. Memish,et al.  Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study , 2013, The Lancet Infectious Diseases.